These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23028738)
1. NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner. Hebar A; Rütgen BC; Selzer E PLoS One; 2012; 7(9):e45015. PubMed ID: 23028738 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity. Plasencia C; Grande F; Oshima T; Cao X; Yamada R; Sanchez T; Aiello F; Garofalo A; Neamati N Cancer Biol Ther; 2009 Mar; 8(5):458-65. PubMed ID: 19221468 [TBL] [Abstract][Full Text] [Related]
3. Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells. Zhang GH; Yuan JM; Qian G; Gu CX; Wei K; Mo DL; Qin JK; Peng Y; Zhou ZP; Pan CX; Su GF J Med Chem; 2017 Aug; 60(16):6853-6866. PubMed ID: 28745887 [TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells. Wang Y; Compton C; Rankin GO; Cutler SJ; Rojanasakul Y; Tu Y; Chen YC Int J Oncol; 2017 Apr; 50(4):1392-1402. PubMed ID: 28259974 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides. Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Li B; Hou D; Guo H; Zhou H; Zhang S; Xu X; Liu Q; Zhang X; Zou Y; Gong Y; Shao C Sci Rep; 2017 Mar; 7(1):208. PubMed ID: 28303009 [TBL] [Abstract][Full Text] [Related]
7. p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775. Hauge S; Macurek L; Syljuåsen RG Cell Cycle; 2019 Apr; 18(8):834-847. PubMed ID: 30943845 [TBL] [Abstract][Full Text] [Related]
9. Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis. Li YL; Gan XL; Zhu RP; Wang X; Liao DF; Jin J; Huang Z Anticancer Agents Med Chem; 2020; 20(4):504-517. PubMed ID: 31721706 [TBL] [Abstract][Full Text] [Related]
10. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells. Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014 [TBL] [Abstract][Full Text] [Related]
11. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways. Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845 [TBL] [Abstract][Full Text] [Related]
12. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation. Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884 [TBL] [Abstract][Full Text] [Related]
13. A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53. Ghosh A; Sengupta A; Seerapu GPK; Nakhi A; Shivaji Ramarao EVV; Bung N; Bulusu G; Pal M; Haldar D Biochem Biophys Res Commun; 2017 Jul; 488(3):562-569. PubMed ID: 28526414 [TBL] [Abstract][Full Text] [Related]
14. Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents. Leijen S; Beijnen JH; Schellens JH Curr Clin Pharmacol; 2010 Aug; 5(3):186-91. PubMed ID: 20406171 [TBL] [Abstract][Full Text] [Related]
15. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells. Song J; Yu J; Jeong LS; Lee SK Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425 [TBL] [Abstract][Full Text] [Related]
16. The synthesis and anticancer activity of 2-styrylquinoline derivatives. A p53 independent mechanism of action. Mrozek-Wilczkiewicz A; Kuczak M; Malarz K; Cieślik W; Spaczyńska E; Musiol R Eur J Med Chem; 2019 Sep; 177():338-349. PubMed ID: 31158748 [TBL] [Abstract][Full Text] [Related]
17. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells. Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359 [TBL] [Abstract][Full Text] [Related]
18. Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide. Sato Y; Kurose A; Ogawa A; Ogasawara K; Traganos F; Darzynkiewicz Z; Sawai T Cancer Biol Ther; 2009 Mar; 8(5):452-7. PubMed ID: 19305157 [TBL] [Abstract][Full Text] [Related]
19. Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity. Grande F; Aiello F; Garofalo A; Neamati N Mini Rev Med Chem; 2016; 16(8):644-50. PubMed ID: 26955877 [TBL] [Abstract][Full Text] [Related]
20. DNA damage and cell cycle arrest induced by protoporphyrin IX in sarcoma 180 cells. Li Q; Wang X; Zhang K; Li X; Liu Q; Wang P Cell Physiol Biochem; 2013; 32(3):778-88. PubMed ID: 24080830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]